Feb. 1, 2012 (China Knowledge) - China
Botanic Pharmaceutical Inc<CBP>, a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines, has posted US$5.4 million-net profit for the fourth quarter of fiscal year 2011 ended Oct. 31, 2011, compared with US$5.6 million the firm realized in the same quarter of fiscal year 2010.
Diluted earnings per American Depositary Share were US$0.14 in the fourth quarter of fiscal year 2011, less than US$0.15 in the corresponding period of fiscal year 2010.
In the three-month period ended Oct. 31, 2011, the U.S.-listed company reaped US$18.8 million in operating revenue, reflecting a year-on-year increase of 12.8% from US$16.7 million. Gross profit increased by 18.5% to US$10.8 million with gross margin of 57.1%.
In the fiscal year 2011, the Chinese pharmaceutical firm's net profit grew from US$17.9 million to US$25.9 million, and its diluted earnings per ADS increased to US$0.69.
Operating revenue for the fiscal year 2011 totaled US$72.7 million, up 31.8% year on year from US$55.2 million.
As of Oct. 31, 2011, China
Botanic Pharmaceutical had US$15.3 million in cash.
For fiscal year 2012, the company expects its revenues to be in the range of US$91.6 million to US$93.1 million, representing an increase of 26% to 28% from a year earlier.